Literature DB >> 29893492

An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People.

Sanae Hayashi1, Anis Khan1, Brenna C Simons2, Chriss Homan2, Takeshi Matsui3, Kenji Ogawa4, Keigo Kawashima1, Shuko Murakami1, Satoru Takahashi5, Masanori Isogawa1, Kazuho Ikeo6, Masashi Mizokami7, Brian J McMahon2, Yasuhito Tanaka1.   

Abstract

Hepatitis B virus (HBV) genotype F1b infection is strongly associated with hepatocellular carcinoma (HCC) in young Alaskan Native (AN) people. However, the mechanisms by which genotype F1b causes HCC are unclear. Here, we analyzed the clinical and virological significance of genotype F1b in long-term serial samples from 20 HCC patients with HBV infection. Complete sequence analyses revealed that all isolates were genotype F1b. In the HCC patients, T1938C and A2051C mutations in the core region had accumulated significantly with A1762T/G1764A mutations in the basal core promoter (BCP) region and G1896A mutation in the precore (PC) region. Several HBV clones containing the core mutations were examined for their replication efficiency and core stability in vitro. Clones containing the A2051C mutation replicated more efficiently than the wild type in association with enhanced stability of core protein dimerization. In chimeric mice with human hepatocytes carrying BCP/PC/2051 mutant but not with wild-type virus, liver fibrosis was induced in association with high levels of serum HBV DNA and hepatitis B surface antigen. Interestingly, microarray analysis and validation study showed that five genes associated with cell proliferation or carcinogenesis, v-myc avian myelocytomatosis viral oncogene homolog, Grb2-associated binding protein 2, bradykinin receptor B2, follistatin, and mitogen-activated protein kinase kinase kinase 8, were significantly up-regulated in human hepatocytes infected with genotype F1b, particularly the BCP/PC/2051 mutant, compared with other genotypes.
Conclusion: We have identified an association between Alaska-specific core mutations and HCC development in AN people infected with genotype F1b; accumulation of these core mutations during the course of chronic infection with genotype F1b would contribute to HCC development in AN people earlier in life.
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2018        PMID: 29893492     DOI: 10.1002/hep.30111

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  Viral Kinetics of an Acute Hepatitis B Virus Subgenotype F1b Infection in a Mexican Subject.

Authors:  Arturo Panduro; Sonia Roman; Nora A Fierro; João R Rebello-Pinho
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-03-10

2.  Hepatitis B Virus Core Variants, Liver Fibrosis, and Hepatocellular Carcinoma.

Authors:  Gaetan Ligat; Catherine Schuster; Thomas F Baumert
Journal:  Hepatology       Date:  2019-01       Impact factor: 17.298

Review 3.  Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics.

Authors:  Shivali S Joshi; Carla S Coffin
Journal:  Hepatol Commun       Date:  2020-01-02

4.  Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology.

Authors:  Chimaobi M Anugwom; Manon Allaire; Sheikh Mohammad Fazle Akbar; Amir Sultan; Steven Bollipo; Angelo Z Mattos; Jose D Debes
Journal:  Hepatoma Res       Date:  2021-03-26

Review 5.  Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins.

Authors:  Sanae Hayashi; Katsuya Nagaoka; Yasuhito Tanaka
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

6.  The Effects and Underlying Mechanisms of Hepatitis B Virus X Gene Mutants on the Development of Hepatocellular Carcinoma.

Authors:  Rui Pu; Wenbin Liu; Xinyu Zhou; Xi Chen; Xiaomei Hou; Shiliang Cai; Liping Chen; Jianfeng Wu; Fan Yang; Xiaojie Tan; Jianhua Yin; Xin Wang; Guangwen Cao
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

7.  Cellular Id1 inhibits hepatitis B virus transcription by interacting with the novel covalently closed circular DNA-binding protein E2F4.

Authors:  Jie Wei; Yueyuan Shi; Chunhong Zou; Hongpeng Zhang; Hui Peng; Shilei Wang; Lulu Xia; Yuan Yang; Xiang Zhang; Junye Liu; Hua Zhou; Miao Luo; Ailong Huang; Deqiang Wang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

8.  Precore/core mutations of hepatitis B virus genotype D arising in different states of infection.

Authors:  Neda Sanaei; Seyed Mohammad Ali Hashemi; Seyedeh Zahra Salehi Dehno; Mozhde Mahmoudi Asl; Maryam Moini; Seyed Ali Malek-Hosseini; Seyed Younes Hosseini; Jamal Sarvari
Journal:  Clin Exp Hepatol       Date:  2022-03-23

9.  Molecular and biological characterization of hepatitis B virus subgenotype F1b clusters: Unraveling its role in hepatocarcinogenesis.

Authors:  María Mercedes Elizalde; Laura Mojsiejczuk; Micaela Speroni; Belén Bouzas; Luciana Tadey; Lilia Mammana; Rodolfo Héctor Campos; Diego Martín Flichman
Journal:  Front Microbiol       Date:  2022-07-27       Impact factor: 6.064

Review 10.  Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection?

Authors:  Masataka Tsuge
Journal:  Viruses       Date:  2021-09-24       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.